Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Blood
|
November 15, 2013
Inhibitory FcγRIIb (CD32b) becomes activated by therapeutic mAb in both cis and trans and drives internalization according to antibody specificity
Andrew T Vaughan, Chisako Iriyama, Stephen A Beers, et al.
Cancer Medicine
|
July 28, 2023
Utility of cerebrospinal fluid liquid biopsy in distinguishing CNS lymphoma from cerebrospinal infectious/demyelinating diseases
Chisako Iriyama, Kenichiro Murate, Sachiko Iba, et al.
International Journal of Hematology
|
September 29, 2022
Safety and antitumor activity of copanlisib in Japanese patients with relapsed/refractory indolent non-Hodgkin lymphoma: a phase Ib/II study
Noriko Fukuhara, Dai Maruyama, Kiyohiko Hatake, et al.
Cancer Science
|
June 6, 2017
Phase II study of intrabone single unit cord blood transplantation for hematological malignancies
Makoto Murata, Yoshinobu Maeda, Masayoshi Masuko, et al.
Blood Advances
|
January 13, 2022
CD19-positive lymphocyte count is critical for acquisition of anti-SARS-CoV-2 IgG after vaccination in B-cell lymphoma
Akinao Okamoto, Hidetsugu Fujigaki, Chisako Iriyama, et al.
Plos One
|
March 24, 2016
Correction: Evaluation of High-Throughput Genomic Assays for the Fc Gamma Receptor Locus
Chantal E Hargreaves, Chisako Iriyama, Matthew J J Rose-Zerilli, et al.
Blood Advances
|
July 29, 2021
Single-nucleotide Fcγ receptor polymorphisms do not impact obinutuzumab/rituximab outcome in patients with lymphoma
Jonathan C Strefford, Malgorzata Nowicka, Chantal E Hargreaves, et al.
Plos One
|
November 7, 2015
Evaluation of High-Throughput Genomic Assays for the Fc Gamma Receptor Locus
Chantal E Hargreaves, Chisako Iriyama, Matthew J J Rose-Zerilli, et al.
PNAS Nexus
|
March 31, 2025
Clinical and molecular landscape of prolonged SARS-CoV-2 infection with resistance to remdesivir in immunocompromised patients
Chisako Iriyama, Takaya Ichikawa, Tomokazu Tamura, et al.
Frontiers in Oncology
|
November 21, 2025
Severe and/or prolonged COVID-19 in hematologic diseases: clinical implications before and during the omicron era
Akinao Okamoto, Masahiro Yoshida, Senji Kasahara, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Blood
|
November 15, 2013
Inhibitory FcγRIIb (CD32b) becomes activated by therapeutic mAb in both cis and trans and drives internalization according to antibody specificity
Andrew T Vaughan, Chisako Iriyama, Stephen A Beers, et al.
Cancer Medicine
|
July 28, 2023
Utility of cerebrospinal fluid liquid biopsy in distinguishing CNS lymphoma from cerebrospinal infectious/demyelinating diseases
Chisako Iriyama, Kenichiro Murate, Sachiko Iba, et al.
International Journal of Hematology
|
September 29, 2022
Safety and antitumor activity of copanlisib in Japanese patients with relapsed/refractory indolent non-Hodgkin lymphoma: a phase Ib/II study
Noriko Fukuhara, Dai Maruyama, Kiyohiko Hatake, et al.
Cancer Science
|
June 6, 2017
Phase II study of intrabone single unit cord blood transplantation for hematological malignancies
Makoto Murata, Yoshinobu Maeda, Masayoshi Masuko, et al.
Blood Advances
|
January 13, 2022
CD19-positive lymphocyte count is critical for acquisition of anti-SARS-CoV-2 IgG after vaccination in B-cell lymphoma
Akinao Okamoto, Hidetsugu Fujigaki, Chisako Iriyama, et al.
Plos One
|
March 24, 2016
Correction: Evaluation of High-Throughput Genomic Assays for the Fc Gamma Receptor Locus
Chantal E Hargreaves, Chisako Iriyama, Matthew J J Rose-Zerilli, et al.
Blood Advances
|
July 29, 2021
Single-nucleotide Fcγ receptor polymorphisms do not impact obinutuzumab/rituximab outcome in patients with lymphoma
Jonathan C Strefford, Malgorzata Nowicka, Chantal E Hargreaves, et al.
Plos One
|
November 7, 2015
Evaluation of High-Throughput Genomic Assays for the Fc Gamma Receptor Locus
Chantal E Hargreaves, Chisako Iriyama, Matthew J J Rose-Zerilli, et al.
PNAS Nexus
|
March 31, 2025
Clinical and molecular landscape of prolonged SARS-CoV-2 infection with resistance to remdesivir in immunocompromised patients
Chisako Iriyama, Takaya Ichikawa, Tomokazu Tamura, et al.
Frontiers in Oncology
|
November 21, 2025
Severe and/or prolonged COVID-19 in hematologic diseases: clinical implications before and during the omicron era
Akinao Okamoto, Masahiro Yoshida, Senji Kasahara, et al.
Page
of 4